GlassScriptPhysician profile
Alexa Bouts
NPI 1316514870
$1,386.60
in general payments reported to CMS, 2019-2025
13 companies · $655 in 2025
The $655 reported for 2025 was more than what 76% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $207 · 2024: $525 · 2025: $655.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,387.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,386.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $182.07 | 2025 | Sapien 3 Ultra Resilia |
| Inspire Medical Systems, INC. | $129.88 | 2025 | Inspire |
| Astellas Pharma US INC | $125.00 | 2023 | Cresemba |
| Bayer Healthcare Pharmaceuticals INC. | $124.80 | 2025 | |
| Lilly USA, LLC | $121.33 | 2024 | Mounjaro |
| Sanofi-Aventis U.S. LLC | $121.17 | 2025 | |
| Glaxosmithkline, LLC. | $121.17 | 2024 | Shingrix |
| Abbott Laboratories | $102.15 | 2024 | Freestyle Libre 3 |
| Lexicon Pharmaceuticals, INC. | $90.72 | 2024 | Inpefa |
| Curonix LLC | $89.61 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Inari Medical, INC. | $81.70 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.19 | 2025 | Jardiance |
| Highridge Medical LLC | $18.81 | 2025 | Invizia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexa Bouts listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.